143 related articles for article (PubMed ID: 30123885)
1. Favorable Long-Term Outcome in Male Breast Cancer.
Özkurt E; Tükenmez M; Yılmaz R; Cabioğlu N; Müslümanoğlu M; Dinççağ AS; İğci A; Özmen V
Eur J Breast Health; 2018 Jul; 14(3):180-185. PubMed ID: 30123885
[TBL] [Abstract][Full Text] [Related]
2. Male breast cancer: A closer look at patient and tumor characteristics and factors associated with survival.
Zhao J; Wang B; Zhao J; Mao Y; Liu J; Yang Y
Thorac Cancer; 2020 Nov; 11(11):3107-3116. PubMed ID: 32930510
[TBL] [Abstract][Full Text] [Related]
3. A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC).
Yu XF; Yang HJ; Yu Y; Zou DH; Miao LL
PLoS One; 2015; 10(8):e0136670. PubMed ID: 26313461
[TBL] [Abstract][Full Text] [Related]
4. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
Zhang HM; Zhang BN; Xuan LX; Zhao P
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
[TBL] [Abstract][Full Text] [Related]
5. Male breast cancer in the veterans affairs population: a comparative analysis.
Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R
Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic characteristics and survival of male breast cancer.
Liu D; Xie G; Chen M
Int J Clin Oncol; 2014 Apr; 19(2):280-7. PubMed ID: 23640121
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Korean Male Breast Cancer Using an Online Nationwide Breast-Cancer Database: Matched-Pair Analysis of Patients With Female Breast Cancer.
Choi MY; Lee SK; Lee JE; Park HS; Lim ST; Jung Y; Ko BK; Nam SJ;
Medicine (Baltimore); 2016 Apr; 95(16):e3299. PubMed ID: 27100414
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and Immunohistochemical Characteristics in Male Breast Cancer: A Retrospective Case Series.
Masci G; Caruso M; Caruso F; Salvini P; Carnaghi C; Giordano L; Miserocchi V; Losurdo A; Zuradelli M; Torrisi R; Di Tommaso L; Tinterri C; Testori A; Garcia-Etienne CA; Gatzemeier W; Santoro A
Oncologist; 2015 Jun; 20(6):586-92. PubMed ID: 25948676
[TBL] [Abstract][Full Text] [Related]
9. Hormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients.
Li X; Yang J; Krishnamurti U; Huo L; Ward KC; O'Regan R; Peng L
Clin Breast Cancer; 2017 Aug; 17(5):356-366. PubMed ID: 28576631
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and prognostic factors of male breast cancer
Sang G; Pan H; Lu C; Sun R; Zha X; Wang S; Zhu D
Transl Cancer Res; 2021 May; 10(5):2199-2209. PubMed ID: 35116538
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features of male patients with breast cancer based on a nationwide registry database in Japan.
Shimomura A; Nagahashi M; Kumamaru H; Aogi K; Asaga S; Hayashi N; Iijima K; Kadoya T; Kojima Y; Kubo M; Miyashita M; Miyata H; Niikura N; Ogo E; Tamura K; Tanakura K; Yoshida M; Yamamoto Y; Imoto S; Jinno H
Breast Cancer; 2022 Nov; 29(6):985-992. PubMed ID: 35733033
[TBL] [Abstract][Full Text] [Related]
12. Hormone receptor-positive breast cancer and black race: does sex matter?
Eskander MF; Li Y; Bhattacharyya O; Tsung A; Oppong BA; Hamad A; Gatti-Mays M; Obeng-Gyasi S
Breast Cancer Res Treat; 2021 Nov; 190(1):111-119. PubMed ID: 34383180
[TBL] [Abstract][Full Text] [Related]
13. Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis.
Fields EC; DeWitt P; Fisher CM; Rabinovitch R
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):747-52. PubMed ID: 24138917
[TBL] [Abstract][Full Text] [Related]
14. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
15. Male Breast Cancer Prognostic Factors Versus Female Counterparts with Propensity Scores and Matched-Pair Analysis.
Yu E; Stitt L; Vujovic O; Joseph K; Assouline A; Younus J; Perera F; Tai P
Cureus; 2015 Oct; 7(10):e355. PubMed ID: 26623210
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics and prognosis of patients with ipsilateral breast tumor recurrence after breast conservation therapy].
Sun GY; Wang SL; Tang Y; Jin J; Song YW; Liu YP; Wang WH; Fang H; Chen SY; Ren H; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):352-358. PubMed ID: 29860762
[No Abstract] [Full Text] [Related]
17. Gender Disparity in Breast Cancer: A Veteran Population-Based Comparison.
Aggarwal A; Adepoju B; Yacur M; Maron D; Sharma MC
Clin Breast Cancer; 2021 Aug; 21(4):e471-e478. PubMed ID: 33619003
[TBL] [Abstract][Full Text] [Related]
18. Hormone receptors and HER-2 status as surrogates for breast cancer molecular subtypes prognosticate for disease control in node negative Asian patients treated with breast conservation therapy.
Wong FY; Chin FK; Lee KA; Soong YL; Chua ET
Ann Acad Med Singap; 2011 Feb; 40(2):90-6. PubMed ID: 21468463
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
20. Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits.
Wang B; Wang H; Zhao A; Zhang M; Yang J
BMC Cancer; 2021 May; 21(1):523. PubMed ID: 33964913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]